Filtern
Volltext vorhanden
- ja (18)
Gehört zur Bibliographie
- ja (18)
Dokumenttyp
Sprache
- Englisch (18)
Schlagworte
- melanoma (5)
- BRAF (2)
- PD-1 (2)
- angiogenesis (2)
- immunohistochemistry (2)
- machine learning (2)
- B7-H1 Antigen (1)
- BARF-mutated melanoma (1)
- BRAF mutation (1)
- COVID-19 (1)
- COX2 expression (1)
- CTLA-4 Antigen (1)
- Cancer Cell (1)
- Cx43 (1)
- Drug Therapy, Combination (1)
- Immune-related adverse event (1)
- Ipilimumab (1)
- Kaposi sarcoma (1)
- Merkel cell carcinoma (1)
- Minimal change disease (1)
- NRF2 (1)
- Nivolumab (1)
- PD‐L1 (1)
- PRAME (1)
- Programmed Cell Death 1 Receptor (1)
- Raman (1)
- SARS-CoV-2 (1)
- SERS (1)
- Skin Neoplasms (1)
- Sunitinib (1)
- Tyrosine kinase inhibition (1)
- adjuvant treatment (1)
- at-home sampling (1)
- avelumab (1)
- biomarker (1)
- checkpoint blocker (1)
- combined targeted therapy (1)
- cutaneous angiosarcoma (1)
- dabrafenib (1)
- drug monitoring (1)
- eosinophils (1)
- gold nanoparticles (1)
- hemangioma (1)
- high-risk Prostate Cancer (1)
- hydroxy-dabrafenib (1)
- immune checkpoint blockade (1)
- immune infiltration (1)
- immunology (1)
- ipilimumab (1)
- kidney cancer (1)
- lactate dehydrogenase (1)
- mRNA (1)
- mTOR (1)
- melanocytic markers (1)
- melanoma malignancy (1)
- miRNA (1)
- microRNA-221 (1)
- mitochondrial DNA (1)
- mtDNA (1)
- nivolumab (1)
- pan-RCC (1)
- population pharmacokinetics (1)
- programmed cell death receptor-1 (1)
- resistance (1)
- rhabdoid differentiation (1)
- rhabdoid melanoma (1)
- targeted therapy (1)
- therapy (1)
- trametinib (1)
- transcriptome (1)
- tumor microenvironment (1)
- volumetric absorptive micro-sampling (VAMS) (1)
Institut
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (18)
- Urologische Klinik und Poliklinik (4)
- Medizinische Klinik und Poliklinik II (3)
- Pathologisches Institut (3)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Center for Computational and Theoretical Biology (2)
- Medizinische Klinik und Poliklinik I (2)
- Comprehensive Cancer Center Mainfranken (1)
- Institut für Pharmazie und Lebensmittelchemie (1)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (1)
Sonstige beteiligte Institutionen
(1) Background: C-X-C Motif Chemokine Receptor 4 (CXCR4) and Fibroblast Activation Protein Alpha (FAP) are promising theranostic targets. However, it is unclear whether CXCR4 and FAP positivity mark distinct microenvironments, especially in solid tumors. (2) Methods: Using Random Forest (RF) analysis, we searched for entity-independent mRNA and microRNA signatures related to CXCR4 and FAP overexpression in our pan-cancer cohort from The Cancer Genome Atlas (TCGA) database — representing n = 9242 specimens from 29 tumor entities. CXCR4- and FAP-positive samples were assessed via StringDB cluster analysis, EnrichR, Metascape, and Gene Set Enrichment Analysis (GSEA). Findings were validated via correlation analyses in n = 1541 tumor samples. TIMER2.0 analyzed the association of CXCR4 / FAP expression and infiltration levels of immune-related cells. (3) Results: We identified entity-independent CXCR4 and FAP gene signatures representative for the majority of solid cancers. While CXCR4 positivity marked an immune-related microenvironment, FAP overexpression highlighted an angiogenesis-associated niche. TIMER2.0 analysis confirmed characteristic infiltration levels of CD8+ cells for CXCR4-positive tumors and endothelial cells for FAP-positive tumors. (4) Conclusions: CXCR4- and FAP-directed PET imaging could provide a non-invasive decision aid for entity-agnostic treatment of microenvironment in solid malignancies. Moreover, this machine learning workflow can easily be transferred towards other theranostic targets.